Survey
Quarterly Survey: Bradycardia and Implantable Pacemakers Usage Trends and Preferences April 2024
Ticker(s): MDT, ABT, BSX, BIOTRONIKThe individual survey results include 20 Cardiologists.
How many patients with bradycardia do you see on average each month?
How would you best describe your practice?
- Community
- Academic
- Other
How many of your bradycardia patients do you consider eligible for an implantable pacemaker?
What is the total number of bradycardia patients that currently use an implantable pacemaker?
How many pacemaker implant surgeries have you performed in the last 30 days?
How many pacemaker implant surgeries do you anticipate to perform in the next 30 days?
What is the percentage breakdown of implantable pacemaker device brands you currently use?
- Micra AV/Micra VR (Medtronic):
- Azure (Medtronic):
- Assurity MRI (Abbott):
- Aveir VR (Abbott):
- Accolade MRI (Boston Scientific):
- Essentio MRI (Boston Scientific):
- Edora (Biotronik):
- Other:
What is the percentage breakdown of implantable pacemaker device brands you expect to use in 1 year?
- Micra AV/Micra VR (Medtronic):
- Azure (Medtronic):
- Assurity MRI (Abbott):
- Aveir VR (Abbott):
- Accolade MRI (Boston Scientific):
- Essentio MRI (Boston Scientific):
- Edora (Biotronik):
- Other:
Which brand of the implantable pacemaker device do you prefer?
Regarding the previous answer. Why do you prefer the implantable pacemaker brand you selected?
How often do you consider cost in your implantable pacemaker brand decision?
What features being added to future generations of implantable pacemakers would have you consider switching manufacturers or significantly shifting share?
What additional information is important/relevant in understanding how physicians make brand decisions about implantable pacemaker devices?
What is the most exciting new device/area of development in your specialty?
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
